NEWPORT BEACH, Calif.--(BUSINESS WIRE)--July 24, 2006--Acacia Research Corporation (Nasdaq:CBMX - News; Nasdaq:ACTG - News) announced today that Dr. Shelly Gunn, M.D., Ph.D., has joined CombiMatrix Molecular Diagnostics (CMDX) as its Medical Director. “I am very impressed with CMDX’s scientific and technical competency in the areas of BAC CGH arrays and high density oligo-based expression arrays,” said Dr. Gunn. “I am excited to be part of the CMDX team and I look forward to helping build the company’s clinical capabilities.”
